Search

everythinglearnresearchcommunity

for

Search:↓

Nilotinib can cause keratosis pilaris, a skin condition.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

A woman's hair turned white after taking a cancer drug called dasatinib.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Targeted cancer therapies often cause serious skin problems that need careful management.

Gray hair can potentially be reversed, leading to new treatments.

Nilotinib can cause generalized keratosis pilaris.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.